• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PI3K抑制剂LY294002通过凋亡介导的甲状腺髓样癌生长抑制作用

Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002.

作者信息

Kunnimalaiyaan Muthusamy, Ndiaye Mary, Chen Herbert

机构信息

Department of Surgery, Section of Endocrine Surgery, Endocrine Surgery Research Laboratories, The University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA.

出版信息

Surgery. 2006 Dec;140(6):1009-14; discussion 1014-5. doi: 10.1016/j.surg.2006.06.040. Epub 2006 Nov 1.

DOI:10.1016/j.surg.2006.06.040
PMID:17188151
Abstract

BACKGROUND

Medullary thyroid cancer (MTC) cells exhibit frequent activation of the PI3K pathway as evidenced by the presence of hyperactivation of Akt kinases and overexpression of neuroendocrine (NE) markers. We hypothesized that the inhibition of the PI3K pathway in MTC may lead to a reduction in cell growth and NE tumor marker production.

METHODS

Human MTC-TT cells were treated with the PI3K inhibitor LY294002 (0-60 micromol/L) for 8 days, and cellular growth was measured. Further, TT cells were treated with nontoxic concentrations of LY294002 for 2 days, and Western blot analyses were performed for phospho-Akt, total Akt, and the NE tumor markers CgA and human achaete-scute homolog1 (ASCL1).

RESULTS

Treatment of TT cells with LY294002 significantly suppressed levels of phospho-Akt. Notably, a dose-dependent reduction in cellular proliferation was also observed. Importantly, NE marker production was also reduced. Mechanistically, we show that cell growth inhibition by PI3K inactivation is mediated by apoptosis attributable to an increase in the levels of cleaved poly(ADP-ribose) polymerase and caspase-3.

CONCLUSIONS

MTC cell growth and NE marker production appear to depend on activation of the PI3K-signaling cascade. Inhibition of this important signal transduction pathway may lead to a possible therapeutic strategy to treat patients with MTC.

摘要

背景

甲状腺髓样癌(MTC)细胞中PI3K通路频繁激活,Akt激酶过度激活和神经内分泌(NE)标志物过表达证明了这一点。我们假设抑制MTC中的PI3K通路可能导致细胞生长和NE肿瘤标志物产生减少。

方法

用PI3K抑制剂LY294002(0 - 60 μmol/L)处理人MTC - TT细胞8天,并测量细胞生长。此外,用无毒浓度的LY294002处理TT细胞2天,对磷酸化Akt、总Akt以及NE肿瘤标志物嗜铬粒蛋白A(CgA)和人无翅型MMTV整合位点家族成员1(ASCL1)进行蛋白质免疫印迹分析。

结果

用LY294002处理TT细胞可显著抑制磷酸化Akt水平。值得注意的是,还观察到细胞增殖呈剂量依赖性降低。重要的是,NE标志物的产生也减少了。从机制上讲,我们表明PI3K失活对细胞生长的抑制作用是由凋亡介导的,这归因于裂解的聚(ADP - 核糖)聚合酶和半胱天冬酶 - 3水平的增加。

结论

MTC细胞生长和NE标志物产生似乎依赖于PI3K信号级联的激活。抑制这一重要的信号转导通路可能为治疗MTC患者带来一种可行的治疗策略。

相似文献

1
Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002.PI3K抑制剂LY294002通过凋亡介导的甲状腺髓样癌生长抑制作用
Surgery. 2006 Dec;140(6):1009-14; discussion 1014-5. doi: 10.1016/j.surg.2006.06.040. Epub 2006 Nov 1.
2
Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer.白藜芦醇诱导神经内分泌标志物在甲状腺髓样癌中 Notch2 介导的细胞凋亡和抑制。
Ann Surg Oncol. 2011 May;18(5):1506-11. doi: 10.1245/s10434-010-1488-z. Epub 2010 Dec 24.
3
MK-2206 causes growth suppression and reduces neuroendocrine tumor marker production in medullary thyroid cancer through Akt inhibition.MK-2206 通过抑制 Akt 引起甲状腺髓样癌的生长抑制和减少神经内分泌肿瘤标志物的产生。
Ann Surg Oncol. 2013 Nov;20(12):3862-8. doi: 10.1245/s10434-013-3168-2. Epub 2013 Jul 31.
4
Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.辛二酰双羟肟酸激活Notch-1信号通路并诱导甲状腺髓样癌细胞凋亡。
Oncologist. 2008 Feb;13(2):98-104. doi: 10.1634/theoncologist.2007-0190.
5
Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors.抑制磷脂酰肌醇3-激酶/蛋白激酶B信号传导可抑制胃肠道类癌肿瘤中的肿瘤细胞增殖和神经内分泌标志物表达。
Ann Surg Oncol. 2009 Oct;16(10):2936-42. doi: 10.1245/s10434-009-0591-5. Epub 2009 Jul 9.
6
Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.辛二酰双羟肟酸在甲状腺髓样癌动物模型中激活Notch1信号通路并抑制肿瘤进展。
Ann Surg Oncol. 2008 Sep;15(9):2600-5. doi: 10.1245/s10434-008-0006-z. Epub 2008 Jun 18.
7
LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.LY294002 和二甲双胍协同增强对卵巢癌细胞生长的抑制和凋亡的诱导。
Int J Gynecol Cancer. 2012 Jan;22(1):15-22. doi: 10.1097/IGC.0b013e3182322834.
8
Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine.抑制 PI3K/Akt 通路可提高胃癌对长春新碱的化疗敏感性。
Oncol Rep. 2013 Aug;30(2):773-82. doi: 10.3892/or.2013.2520. Epub 2013 Jun 5.
9
Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.非小细胞肺癌细胞对磷脂酰肌醇3激酶/Akt和丝裂原活化蛋白激酶激酶4/c-Jun氨基末端激酶途径抑制剂的反应:一种有效的肺癌治疗策略。
Clin Cancer Res. 2005 Aug 15;11(16):6065-74. doi: 10.1158/1078-0432.CCR-05-0009.
10
Hemangiopoietin inhibits apoptosis of MO7e leukemia cells through phosphatidylinositol 3-kinase-AKT pathway.血管生成素通过磷脂酰肌醇3-激酶-AKT途径抑制MO7e白血病细胞的凋亡。
Biochem Biophys Res Commun. 2004 Apr 23;317(1):198-204. doi: 10.1016/j.bbrc.2004.03.034.

引用本文的文献

1
PI3K Signaling Pathway Inhibitor Affects Myeloma Cells in a Culture-Dependent Manner.PI3K信号通路抑制剂以依赖培养的方式影响骨髓瘤细胞。
Adv Pharm Bull. 2025 Apr 24;15(2):440-452. doi: 10.34172/apb.025.42774. eCollection 2025 Jul.
2
PI3K Inhibition Sensitize the Cisplatin-resistant Human Ovarian Cancer Cell OVCAR3 by Induction of Oxidative Stress.PI3K抑制通过诱导氧化应激使顺铂耐药的人卵巢癌细胞OVCAR3致敏。
Rep Biochem Mol Biol. 2022 Jan;10(4):675-685. doi: 10.52547/rbmb.10.4.675.
3
Bioinformatics Study of Sea Cucumber Peptides as Antibreast Cancer Through Inhibiting the Activity of Overexpressed Protein (EGFR, PI3K, AKT1, and CDK4).
海参肽通过抑制过表达蛋白(表皮生长因子受体、磷脂酰肌醇-3激酶、蛋白激酶B和细胞周期蛋白依赖性激酶4)的活性抗乳腺癌的生物信息学研究
Cancer Inform. 2021 Jul 13;20:11769351211031864. doi: 10.1177/11769351211031864. eCollection 2021.
4
Medullary thyroid cancer: molecular factors, management and treatment.甲状腺髓样癌:分子因素、管理与治疗。
Rom J Morphol Embryol. 2020 Jul-Sep;61(3):681-686. doi: 10.47162/RJME.61.3.06.
5
Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson's Disease.VEGFR2 和 RET 抑制在帕金森病临床前模型中的有害作用。
Mol Neurobiol. 2018 Jan;55(1):201-212. doi: 10.1007/s12035-017-0733-x.
6
The Phosphatidylinositol 3-kinase/Akt Signaling Pathway in Neuroendocrine Tumors.神经内分泌肿瘤中的磷脂酰肌醇3-激酶/蛋白激酶B信号通路
Glob J Biochem. 2012;3. Epub 2011 Mar 8.
7
PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy.甲状腺髓样癌中的PI3K/Akt/mTOR信号传导:一种有前景的癌症治疗分子靶点。
Endocrine. 2015 Mar;48(2):363-70. doi: 10.1007/s12020-014-0380-1. Epub 2014 Aug 13.
8
The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth.新型组蛋白去乙酰化酶抑制剂泰国菌素 A 抑制间变性甲状腺癌生长。
J Surg Res. 2014 Jul;190(1):191-7. doi: 10.1016/j.jss.2014.02.042. Epub 2014 Feb 28.
9
Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer.橙皮素激活Notch1信号级联反应,导致细胞凋亡,并诱导间变性甲状腺癌的细胞分化。
Ann Surg Oncol. 2014 Dec;21 Suppl 4(0 4):S497-504. doi: 10.1245/s10434-013-3459-7. Epub 2014 Jan 14.
10
Current understanding and management of medullary thyroid cancer.当前对甲状腺髓样癌的认识和管理。
Oncologist. 2013;18(10):1093-100. doi: 10.1634/theoncologist.2013-0053. Epub 2013 Sep 13.